人工智慧（AI）藥物研發市場：按治療領域、應用和地區分類

2026年，人工智慧（AI）藥物發現市場規模估計為19.708億美元，預計到2033年將達到55.7億美元。預計從2026年到2033年，該市場將以16.0%的複合年成長率成長。

人工智慧（AI）是建構智慧機器，特別是智慧電腦程式的科學和工程。人工智慧技術可應用於藥物發現、藥物開發、現有藥物的再利用、藥物代謝預測、藥物毒性分析、提高製藥效率、臨床試驗以及幾乎所有藥學領域。所有這些技術統稱為AIDD（人工智慧藥物發現）。

市場動態：

技術進步、市場參與企業的新產品發布、合作關係、研發協議以及市場參與者的其他非內部成長策略預計將成為預測期內全球人工智慧（AI）藥物發現市場成長的主要驅動力。

例如，2023年5月16日，Google雲端在生物資訊技術世界大會上發布了兩項全新的人工智慧生命科學解決方案，旨在加速生物技術公司、製藥公司和公共部門機構的藥物研發和精準醫療。 「標靶和先導化合物識別套件」可幫助研究人員更準確地識別胺基酸功能並預測蛋白質結構，而「多組學套件」則可加速基因組數據的發現和解讀，幫助企業設計精準療法。

本報告的主要特點

• 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
• 本節根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數，對全球人工智慧 (AI) 藥物發現市場中的關鍵公司進行介紹。
• 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
• 《全球人工智慧（AI）藥物發現市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過各種策略矩陣來分析全球人工智慧（AI）藥物發現市場，從而促進決策。

目錄

第1章：分析目標與假設

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 控制藥物研發成本的需求日益成長。
  • 慢性病盛行率的上升正在推動個人化醫療的發展。
  • 巨量資料和資訊在醫療和藥物研發領域的爆炸性成長。
  • 擴大人工智慧在醫學各領域的應用
• 影響分析
• 主要亮點
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特五力分析
• 企業合併情景

第4章：人工智慧（AI）在藥物發現領域的市場

• 供給面和需求面分析
• 經濟影響

第5章：人工智慧（AI）在藥物研發領域的市場：按治療領域分類（2021-2033 年）

• 瘤
• 神經退化性疾病
• 心血管疾病
• 代謝性疾病
• 感染疾病
• 其他

第6章：人工智慧（AI）在藥物研發領域的市場：按應用領域分類（2021-2033 年）

• 藥物最佳化與擴大適應症
• 臨床前試驗
• 其他

第7章：人工智慧（AI）在藥物研發領域的市場：按地區分類（2021-2033 年）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭情勢

• IBM Corporation（Ibm Watson Health）
• Exscientia
• GNS Healthcare
• Alphabet, Inc.（DEEPMIND）
• Benevolent AI
• Biosymetrics
• Euretos
• Berg LLC.
• Atomwise, Inc.

第9章

• 分析方法
• 關於 Coherent Market Insights

Artificial Intelligence in Drug Discovery Market is estimated to be valued at USD 1,970.8 Mn in 2026 and is expected to reach USD 5,570.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 16.0% from 2026 to 2033.

The Artificial intelligence (AI) is the science and engineering of making intelligent machines, especially intelligent computer programs. The AI techniques are also applicable to drug discovery, drug development, drug repurposing, drug metabolism prediction, drug toxicity analysis, improving pharmaceutical productivity, clinical trials and almost all aspects of pharmaceutical sciences. All these techniques are collectively considered under AIDD (Artificial Intelligence in Drug Discovery).

Market Dynamics:

Increasing technological advancements, product launches by market players, collaborations, research and development agreements and other inorganic growth strategies by market players are major factors expected to augment growth of the global artificial intelligence in drug discovery market over the forecast period.

For instance, on May 16 2023, Google Cloud, in Bio-IT World Conference announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global artificial intelligence in drug discovery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include IBM Corporation (Ibm Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc. (DEEPMIND), Benevolent AI, Biosymetrics, Euretos, Berg LLC., Atomwise, Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global artificial intelligence in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in drug discovery market.

Detailed Segmentation:

• Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Space (Revenue, USD Mn, 2021 - 2033)
• Oncology
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Metabolic Diseases
• Infectious Diseases
• Other
• Global Artificial Intelligence in Drug Discovery Market, By Application (Revenue, USD Mn, 2021 - 2033)
• Drug Optimization & Repurposing
• Preclinical Testing
• Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles:
• IBM Corporation (Ibm Watson Health)
• Exscientia
• GNS Healthcare
• Alphabet, Inc. (DEEPMIND)
• Benevolent AI
• Biosymetrics
• Euretos
• Berg LLC.
• Atomwise, Inc.

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapeutic Space
  • Market Snapshot, By Application
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising need to curb drug development and discovery costs
  • Rising prevalence of chronic diseases supporting development of personalized drugs
  • Big data and information explosion in healthcare and drug discovery
  • Growing applications of AI in various healthcare areas
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER€(TM)s Analysis
• Merger and Acquisition Scenario

4. Artificial Intelligence in Drug Discovery Market

• Supply Side and Demand Side Analysis
• Economic Impact

5. Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Neurodegenerative Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Metabolic Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Artificial Intelligence in Drug Discovery Market, By Application, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Drug Optimization & Repurposing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Preclinical Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Artificial Intelligence in Drug Discovery Market, By Geography, 2021 - 2033, (US$ Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2021 - 2033,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)

8. Competitive Landscape

• IBM Corporation (Ibm Watson Health)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Exscientia
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GNS Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alphabet, Inc. (DEEPMIND)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Benevolent AI
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biosymetrics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Euretos
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Berg LLC.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Atomwise, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us